Tonghua Golden-Horse Stock Hits Day Low Amid Price Pressure at CNY 16.73

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. experienced a notable decline today, with its stock price dropping by 4.34% to reach an intraday low of CNY 16.73. This performance contrasts with the broader market, as the China Shanghai Composite index fell by 3.05% on the same day. Over the past month, Tonghua Golden-Horse has faced significant challenges, with a staggering 31.66% decrease in stock value, while the Shanghai Composite saw a more modest decline of 8.37%. Year-to-date, the company's stock has plummeted by 39.07%, significantly underperforming the market, which has only dipped by 5.16%. Financial metrics indicate that the company has struggled with profitability, reflected in a low Return on Capital Employed (ROCE) of 2.62% and a Return on Equity (ROE) of 1.37%. Additionally, the company has reported negative results for the last three consecutive quarters, with net profit declining by 58.14%. Despite being net-debt free, the company has shown poor long-term growth, with net sales decreasing at an annual rate of 2.78% over the past five years.